An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Clinical trial NCT02294461 · COMPLETED
Trial details
- NCT number
- NCT02294461
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-23
- Primary completion
- 2015-09-20
- Enrollment
- 395
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.